Try our Advanced Search for more refined results
Health
-
March 02, 2026
6th Circ. Upholds 12-Year Stint For Mich. Doc In 'Pill Mill' Case
The Sixth Circuit affirmed the convictions and 12-year prison sentence of a Michigan doctor accused of operating a cash-only "pill mill" that wrote thousands of opioid prescriptions, holding that the trial judge properly handled the jury instructions and key evidentiary rulings.
-
March 02, 2026
Hagens Berman Denied Rehearing Bid In Sanctions Dispute
The Third Circuit on Monday rejected plaintiffs firm Hagens Berman Sobol Shapiro LLP's request to reconsider weighing in on the sanctions dispute in a since-dropped product liability case that resulted in the trial court judge referring the firm for possible criminal investigation.
-
March 02, 2026
Gyre, Cullgen Merge In $300M All-Stock Deal
Commercial-stage biopharmaceutical company Gyre Therapeutics Inc. on Monday announced plans to acquire clinical-stage biopharmaceutical company Cullgen Inc. in an all-stock deal valued at roughly $300 million.
-
March 02, 2026
Physical Therapy Practice Owners Get 6 Years For Fraud
The owners of a defunct Erie, Pennsylvania, physical therapy practice were each sentenced to six years in prison for defrauding federal healthcare programs by overbilling, prosecutors announced Monday.
-
March 02, 2026
Catching Up With Delaware's Chancery Court
The Delaware Chancery Court's docket last week featured headline-grabbing disputes involving fast food giant Jack in the Box and boxing legend Mike Tyson's cannabis venture, alongside high-stakes fights over merger documents, appraisal rights and a $75 million renewable energy funding clash.
-
March 02, 2026
Drugmakers Warn Justices Oregon Pricing Law Risks Secrets
Pharmaceutical manufacturers have asked the U.S. Supreme Court to overturn Oregon's drug‑pricing transparency law, arguing it forces companies to publicly justify their pricing decisions and give up valuable trade secrets in violation of the First Amendment and the Constitution's takings clause.
-
March 02, 2026
Pepsi Extinguishes Employee's Tobacco Fee Lawsuit
Pepsi has defeated a proposed class action claiming it unlawfully charged employees who used tobacco more to obtain health insurance, with a New York federal judge shutting down a worker's argument that the company hadn't given tobacco users a sufficient way to avoid the surcharge.
-
February 27, 2026
Recovery Provider Asks For Halt To Anthem's Claims Practices
A Colorado mental health and substance use treatment facilities operator and its patients asked a Colorado federal judge to stop Anthem Blue Cross and Blue Shield's claims practices, alleging its process violates federal benefits and mental health parity laws and disrupts access to lifesaving care.
-
February 27, 2026
Do H-1B Fee Waivers Exist In Practice? Attys Have Doubts
More than five months after President Donald Trump rolled out a $100,000 fee for some H-1B petitions, immigration attorneys say the administration hasn't adjudicated fee exemption requests, leaving them uncertain about whether the waiver is merely notional.
-
February 27, 2026
Emory Escapes Fired Worker's Race, Age Bias Suit
Emory University knocked out a lawsuit from a white former employee who said her race and age got her fired, with a federal judge ruling that she couldn't overcome the school's argument that she'd been terminated for accessing medical records without authorization.
-
February 27, 2026
Fed. Circ. Urged To Undo Attys' DQ In Patent Fight
Two men listed as inventors on allergy test patents asked the Federal Circuit to vacate an order that disqualified attorneys who had represented the pair for almost four years in a case from a Maine physician who claimed he should be the sole inventor.
-
February 27, 2026
3rd Circ. Preview: Janssen, Penn State Prof. Seek Relief
A packed March argument calendar will put several high‑stakes disputes before the Third Circuit, including a billion‑dollar False Claims Act judgment and challenges at the intersection of academic freedom, DEI programming, cannabis‑sector finance and campus Title IX procedures.
-
February 27, 2026
6 Arguments Sessions Benefits Attys Should Watch In March
An ex-Wells Fargo worker will ask the Eighth Circuit to revive a suit challenging 401(k) forfeiture spending, the Trump administration will push the Ninth Circuit to greenlight its transgender health coverage policies and the Fourth Circuit will hear a severance fight from manufacturing plant workers. Here, Law360 looks at six oral argument sessions to watch out for in the coming month.
-
February 27, 2026
Credit Bureaus Fight Bid To Add Plaintiffs, Claims To Suit
Medical providers and a collection agency in a proposed class action accusing Equifax, Experian and TransUnion of conspiring to exclude less than $500 in medical debt from consumer credit reports lack good cause to again amend their complaint, the credit reporting agencies told a federal court.
-
February 27, 2026
Judge Says RFK Jr.-Tied Group Can't Join Childhood Vax Suit
A Massachusetts judge said an anti-vaccine advocacy group with ties to U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. cannot join a lawsuit over the federal government's new childhood vaccine schedule, a day after the government said it opposed the group intervening in the case.
-
February 27, 2026
Latham, Sidley Advise Healthpeak Senior Housing Spinoff IPO
Following a carveout by parent Healthpeak Properties this year, Janus Living, a senior housing-focused real estate investment trust, filed with regulators Friday for an initial public offering advised by Latham & Watkins LLP and Sidley Austin LLP.
-
February 27, 2026
Ga. Court Says Eye Care Cos. Were Wrongly Lumped Together
A Georgia appeals court has sent back to trial court a man's suit alleging medical negligence caused him to develop blindness in one eye after cataract surgery, saying the lower court wrongly found three defendants in the case were alter egos of one another.
-
February 27, 2026
Minn. State Sens. Introduce Medical Psilocybin Bill
A pair of Minnesota state senators have introduced a bill to create and regulate a medical psilocybin use program, which would allow residents over 21 with qualifying medical conditions to cultivate and use the drug to treat their conditions.
-
February 27, 2026
Taxation With Representation: Linklaters, Wilson Sonsini
In this week's Taxation With Representation, French electric utility Engie acquires UK Power Networks, Gilead Sciences Inc. buys clinical-stage biotechnology company Arcellx Inc., and The Brink's Co. acquires NCR Atleos in a deal that unites two major companies in the ATM business.
-
February 27, 2026
Colo. Orthodontist Says Co. Shifted Assets To Nix Her Profits
A Colorado orthodontist who helped build the orthodontics arm of a dental franchise network sued the company and several of its leaders in Colorado state court Friday, alleging they shifted franchise operations among affiliated entities to dilute her ownership stake and deny promised revenue.
-
February 27, 2026
Katten Pushes For Atty Immunity To Non-Clients' Suit In Texas
Katten Muchin Rosenman LLP is asking the Texas Supreme Court to shut down a state court lawsuit brought by co-defendants of a client they successfully represented in a federal criminal investigation over alleged healthcare fraud, saying lower courts that refused to dismiss are seeking to limit the state's "hundred-year-old doctrine" of attorney immunity.
-
February 27, 2026
121-Year-Old Ruling Still A Shot In The Arm For Vax Mandates
Having already withstood five global pandemics, 21 presidencies and more than a century of developments in both the law and public health policy, the U.S. Supreme Court's most durable precedent blessing mandatory vaccination is well positioned to survive a new wave of challenges, experts say.
-
February 27, 2026
NYC Health Center Sues HHS Over $31M Medicare Repayment
The U.S. Department of Health and Human Services is unlawfully attempting to recoup more than $31 million in Medicare overpayments made during the COVID-19 pandemic, a New York City skilled nursing center told a federal court, saying it shouldn't have to repay the money.
-
February 27, 2026
Meta Must Face Worker's Transgender Health Coverage Suit
Meta can't escape a transgender employee's lawsuit claiming the company's health plan unlawfully denied her coverage of gender-affirming surgeries, an Oregon federal judge ruled, rejecting the company's assertion that she hadn't adequately alleged the plan covered her desired procedures.
-
February 27, 2026
Outdoor Pot Grower Can Keep Going During Okla. License Suit
An Oklahoma magistrate judge will let a cannabis cultivator continue its outdoor growing operations while it fights state officials over the revocation of its license, finding that the government's safety arguments are undermined by its own stated policy and actions.
Expert Analysis
-
What Ethics Rules Say On Atty Discipline For Online Speech
Though law firms are free to discipline employees for their online commentary about Charlie Kirk or other social media activity, saying crude or insensitive things on the internet generally doesn’t subject attorneys to professional discipline under the Model Rules of Professional Conduct, says Stacie H. Rosenzweig at Halling & Cayo.
-
Junior Attys Must Beware Of 5 Common Legal Brief Mistakes
Excerpt from Practical Guidance
Junior law firm associates must be careful to avoid five common pitfalls when drafting legal briefs — from including every possible argument to not developing a theme — to build the reputation of a sought-after litigator, says James Argionis at Cozen O'Connor.
-
Assessing Legal, Regulatory Hurdles Of Healthcare Offshoring
The offshoring of administrative, nonclinical functions has emerged as an increasingly attractive option for healthcare companies seeking to reduce costs, but this presents challenges in navigating the web of state restrictions on the access or storage of patient data outside the U.S., say attorneys at McDermott.
-
Lessons As Joint Employer Suits Shift From Rare To Routine
Joint employer allegations now appear so frequently that employers should treat them as part of the ordinary risk landscape, and several recent decisions demonstrate how fluid the liability doctrine has become, says Thomas O’Connell at Buchalter.
-
Texas Suit Marks Renewed Focus On Service Kickback Theory
After a dormant period at the federal level, a theory of kickback enforcement surrounding nurse educator programs and patient support services resurfaced with a recent state court complaint filed by Texas against Eli Lilly, highlighting for drugmakers the ever-changing nature of enforcement priorities and industry landscapes, say attorneys at Sheppard Mullin.
-
Series
Power To The Paralegals: How And Why Training Must Evolve
Empowering paralegals through new models of education that emphasize digital fluency, interdisciplinary collaboration and human-centered lawyering could help solve workforce challenges and the justice gap — if firms, educators and policymakers get on board, say Kristine Custodio Suero and Kelli Radnothy.
-
Series
Playing Softball Makes Me A Better Lawyer
My time on the softball field has taught me lessons that also apply to success in legal work — on effective preparation, flexibility, communication and teamwork, says Sarah Abrams at Baleen Specialty.
-
5 Years In, COVID-19 Fraud Enforcement Landscape Is Shifting
As the government moves pandemic fraud enforcement from small-dollar individual prosecutions to high-value corporate cases, and billions of dollars remain unaccounted for, companies and defense attorneys must take steps now to prepare for the next five years of scrutiny, says attorney David Tarras.
-
Vanda Ruling Opens Door For Contesting FDA Drug Denials
The D.C. Circuit's recent decision in Vanda Pharmaceuticals v. U.S. Food and Drug Administration creates new opportunities and considerations for drug companies navigating the FDA approval process, establishing that litigation is an option when the FDA refuses to hold a hearing, say attorneys at Polsinelli.
-
Series
Law School's Missed Lessons: Mastering Time Management
Law students typically have weeks or months to prepare for any given deadline, but the unpredictability of practicing in the real world means that lawyers must become time-management pros, ready to adapt to scheduling conflicts and unexpected assignments at any given moment, says David Thomas at Honigman.
-
Courts Keep Upping Standing Ante In ERISA Healthcare Suits
As Article III standing becomes increasingly important in litigation brought by employer-sponsored health plan members under the Employee Retirement Income Security Act, several recent cases suggest that courts are taking a more scrutinizing approach to the standing inquiry in both class actions and individual matters, say attorneys at Crowell & Moring.
-
Calif. Bill May Shake Up Healthcare Investment Landscape
If signed by the governor, newly passed California legislation would significantly expand the Office of Health Care Affordability's oversight of private equity and hedge fund investments in healthcare companies and management services organizations, and raise several questions about companies' data confidentiality and filing burdens, say attorneys at Ropes & Gray.
-
How Hyperlinks Are Changing E-Discovery Responsibilities
A recent e-discovery dispute over hyperlinked data in Hubbard v. Crow shows how courts have increasingly broadened the definition of control to account for cloud-based evidence, and why organizations must rethink preservation practices to avoid spoliation risks, says Bree Murphy at Exterro.
-
Pharma Copay Programs Raise Complex Economic Questions
The growing prevalence of copay accumulator and maximizer programs in the pharmaceutical industry is drawing increased scrutiny from patients, advocacy groups, lawmakers and courts, bringing complex questions about how financial responsibility for prescription drug purchases is determined and complicating damages assessments in litigation, say analysts at Analysis Group.
-
State False Claims Acts Can Help Curb Opioid Fund Fraud
State versions of the federal False Claims Act can play an important role in policing the misuse of opioid settlement funds, taking a cue from the U.S. Department of Justice’s handling of federal fraud cases involving pandemic relief funds, says Kenneth Levine at Stone & Magnanini.